NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Application (NDA) for TRIESENCE® (triamcinolone acetonide inject…
Category: Business
Europe Contact Lenses Market Insights Report 2023: A $2.23 Billion Market in 2022 – Forecasts to 2028 with Profiles of Prominent Vendors – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Europe Contact Lenses Market – Focused Insights 2023-2028” report has been added to ResearchAndMarkets.com’s offering. European contact lenses market was valued at $2.23 billion in 2022 and is expected to grow at a CAGR of…
Berlin Cures advances fight against Long COVID on a pan-European level
BERLIN–(BUSINESS WIRE)–Berlin Cures, a biotechnology company specialized in neutralizing functional autoantibodies (fAABs), is expanding its Phase II clinical trial into a pan-European, multi-center collaboration in the fight against Long COVID. A to…
Delta Dental of Tennessee Launches Annual Holiday Campaign With $75,000 Pledge to Children's Hospitals Across Tennessee
NASHVILLE, Tenn.–(BUSINESS WIRE)–Delta Dental of Tennessee launched its annual holiday campaign, pledging a collective $75,000 in donations to children’s hospitals across the state.
Prevent Blindness Georgia Raises $320,000 To Expand Their Vision Saving Initiatives For Underserved Youth and Adults At 7TH Annual Night for Sight Gala
ATLANTA–(BUSINESS WIRE)–Prevent Blindness Georgia (PBGA), the state’s leading voluntary eye health organization dedicated to saving sight and restoring vision, is proud to share that it has successfully raised $320,000 to support its vision saving in…
BTIG to Host 3rd Annual Ophthalmology Day on November 27, 2023
NEW YORK–(BUSINESS WIRE)–BTIG announced today that its 3rd Annual Ophthalmology Day will take place on Monday, November 27, 2023. The virtual, one-day event will include thematic panel discussions, one-on-one meetings and company presentations. The e…
Harrow to Present at Two Investor Conferences in November
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in the following t…
STAAR Surgical to Present at Stephens Annual Investment Conference (NASH2023)
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (ICL) for myopia, astigmatism and presbyopia, today announced that management …
LENZ Therapeutics and Graphite Bio Announce Merger Agreement
SAN DIEGO & SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–LENZ Therapeutics, a late-stage biopharmaceutical company focused on developing and commercializing innovative therapies to improve vision, and Graphite Bio, Inc. (NASDAQ: GRPH) today announced …
Bausch + Lomb Reports More Than 76 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its exclusive ONE by ONE and Biotrue Eye Care Recycling programs h…
Vivani Medical Provides Business Update and Reports Third Quarter Financial Results
ALAMEDA, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today reported financial results for the third quar…
KeraLink International Provides $2.5 Million in Seed Funding to Enable Development of Bioengineered Corneal Implants
BALTIMORE–(BUSINESS WIRE)–KeraLink International invests in novel advancements to help eradicate corneal blindness globally, with emphasis on low- and middle-income countries.
20/20 Onsite Recognized as a Massachusetts Innovation Network 2023 Eddies Winner for Transforming Vision Care
BOSTON–(BUSINESS WIRE)–20/20 Onsite, a Boston-based eye care company, proudly announces its recent achievement at the Massachusetts Innovation Network 2023 Eddies Awards. The company has been honored with the esteemed Eddies Award in the Healthy Livi…
Inflammasome Therapeutics to Enter Clinic with Treatment for Dry AMD
NEWTON, Mass.–(BUSINESS WIRE)– #NRTIs–Inflammasome Therapeutics (https://inflam.com), a private company, developing a new class of inflammasome inhibitor drugs called Kamuvudines as therapies for prevalent, degenerative diseases, announced the FDA h…
Ray Therapeutics Receives $4M in Funding from The California Institute for Regenerative Medicine (CIRM)
SAN FRANCISCO–(BUSINESS WIRE)–Ray Therapeutics Receives $4M in Funding from The California Institute for Regenerative Medicine (CIRM)
LENSAR Reports Third Quarter 2023 Results and Provides Business Update
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial results for the quart…
Glaukos Announces Participation in Stifel Healthcare Conference
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that i…
Inotrem Receives Milestone Funding From the Crohn’s & Colitis Foundation IBD Ventures Program to Advance Its Inflammatory Bowel Disease Pipeline
PARIS–(BUSINESS WIRE)– #biotech–Inotrem receives milestone funding from the Crohn’s & Colitis Foundation following the review of its antibody program interim data.
Inotrem reçoit une deuxième tranche de financement de la Crohn’s & Colitis Foundation, via le fonds IBD Ventures, pour son programme dans les maladies inflammatoires chroniques de l’intestin (MICI)
PARIS–(BUSINESS WIRE)–Inotrem, une société de biotechnologie en phase clinique avancée spécialisée dans l’immunothérapie pour les maladies inflammatoires chroniques et aigües, annonce aujourd’hui avoir reçu une deuxième tranche de financement de la C…
Glaukos Announces Third Quarter 2023 Financial Results
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financ…